Familial clustering of multiple sclerosis in a Dutch genetic isolate

I A Hoppenbrouwers1, L M Pardo Cortes, Y S Aulchenko

  • 1Department of Neurology, MS Centre ErasMS, Erasmus MC, Rotterdam 3015 GD, The Netherlands.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 14, 2007
PubMed

Insights

This study found that multiple sclerosis (MS) patients in a Dutch isolate show significant familial aggregation and inbreeding. This genetically isolated population is valuable for identifying new MS genes.

Area of Science:

  • Genetics
  • Neurology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) has a significant genetic component that remains incompletely understood.
  • Genetically isolated populations offer unique opportunities to study disease aggregation and genetic factors.

Purpose of the Study:

  • To investigate the familial aggregation of multiple sclerosis (MS) within a genetically isolated population in The Netherlands.
  • To assess the degree of relatedness, inbreeding, and kinship among MS patients in this isolate.
  • To explore potential associations with other autoimmune diseases and HLA alleles.

Main Methods:

  • Identification of 48 MS patients from a Dutch isolate.
  • Pedigree analysis using municipal and church records to trace familial relationships.
  • Calculation of inbreeding and kinship coefficients for MS patients and a control group.
  • HLA typing for patients and controls.

Main Results:

  • A significant familial aggregation of MS was observed in the isolate.
  • MS patients exhibited higher rates of relatedness and inbreeding compared to controls.
  • No significant clustering of Type 1 diabetes or autoimmune thyroid diseases was found in MS families.
  • A non-significant trend towards increased prevalence of the HLA DRB1*15 allele in MS patients was noted.

Conclusions:

  • The study confirms familial aggregation of MS in this genetically isolated Dutch population.
  • The high inbreeding level in this isolate makes it a valuable resource for discovering novel genes implicated in MS pathogenesis.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...